CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

ProStat

ProStat is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sentage Corporation

Sentage Corporation is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amsino International

Amsino International is a Pomona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ScienceBased Health

ScienceBased Health is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Optum

Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. Optum comprises three companies â€" OptumHealth, OptumInsight and OptumRx â€" representing more than 35,000 employees worldwide who collaborate to deliver integrated, intelligent solutions that work to modernize the health system and improve overall population health.